Senores Pharma IPO listing Shares debut at bumper 52% premium
30 Dec 2024 //
BUSINESS STD
Senores Pharma IPO Allotment Today: Check Status & GMP
26 Dec 2024 //
BUSINESS STD
Senores Pharma IPO Sees 13.88x Subscription on Day 2
23 Dec 2024 //
BUSINESS STD
Senores IPO Subscribed 1.78x on Day 1 with Strong Retail Demand
20 Dec 2024 //
BUSINESS STD
Senores Sets Rs 372-391 Price Band for Rs 582 Cr IPO Opening Friday
18 Dec 2024 //
BUSINESS STD
Senores Pharma Launches Ivermectin Tablets In US With Dr. Reddy’s
26 Nov 2024 //
PRESS RELEASE
Senores Pharmaceuticals gets SEBI nod for IPO
21 Oct 2024 //
INDPHARMAPOST
Senores`s Generics Topiramate Receives Approval in US
10 Oct 2024 //
FDA
Senores announces the launch of Nicardipine Hydrochloride Capsules
25 Sep 2023 //
PR NEWSWIRE
Senores` Generic Nicardipine Hydrochloride Receives Approval in the U.S.
17 Jul 2023 //
FDA
Senores` Generic Diclofenac Potassium Receives Approval in the U.S.
15 Mar 2023 //
FDA
Dr. Reddy’s, Senores Pharma launch Ketorolac Tromethamine
25 May 2022 //
THE HINDU